Antibody Arrays for Determination of Relative Protein Abundances

  • Grigoriy S. Chaga
Part of the Methods in Molecular Biology™ book series (MIMB, volume 441)

Summary

As a large number of genome-sequencing projects reached completion, the attention of the scientific community is turning toward understanding the structure-functions of gene translation products—the proteins as well as the complete complement of proteins—the proteome. One goal of proteomics is to correlate changes in protein abundance with biological processes and disease states. To help accelerate this avenue of proteomics, a significant effort has been devoted to the development of multiplexed methods for protein analyses. We have developed an Antibody Microarray, a chip-based technology for multiparallel determination of relative abundance of hundreds of proteins. The Antibody Microarray is composed of hundreds of distinct monoclonal antibodies printed at high density on a glass slide. It utilizes a novel experimental setup and data analysis algorithm, which enables scientists to assay hundreds of cytosolic, nuclear, and membrane-bound proteins with a single experiment. Examples of biological samples that are analyzed on the Antibody Microarray include tissue samples, cell cultures, and body fluids.

Key Words

Antibody arrays protein arrays protein abundance multi-parallel protein profiling 

References

  1. 1.
    Aebersold, R., Rist, B. and Gygi, S.P. Quantitative proteome analysis: Methods and applications. Ann N Y Acad Sci 919, 33–47 (2000).CrossRefPubMedGoogle Scholar
  2. 2.
    Chen, G., et al., Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1, 304–313 (2002).CrossRefPubMedGoogle Scholar
  3. 3.
    Haab, B.B. Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Devel 4, 116–123 (2001).PubMedGoogle Scholar
  4. 4.
    Arenkov, P., et al., Protein microchips: Use for immunoassay and enzymatic reactions. Anal Biochem 278, 123–131 (2000).CrossRefPubMedGoogle Scholar
  5. 5.
    Bussow, K., Konthur, Z., Lueking, A., Lehrach, H. and Walter, G. Protein array technology. Potential use in medical diagnostics. Am J Pharmacogenomics 1, 37–43 (2001).CrossRefPubMedGoogle Scholar
  6. 6.
    Huang, R.P., Huang, R., Fan, Y., and Lin, Y. Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal Biochem 294, 55–62 (2001).CrossRefPubMedGoogle Scholar
  7. 7.
    Lueking, A., Horn, M., Eickhoff, H., Bussow, K., Lehrach, H., and Walter, G. Protein microarrays for gene expression and antibody screening. Anal Biochem 270, 103–111 (1999).CrossRefPubMedGoogle Scholar
  8. 8.
    Robinson, W.H., Steinman, L., and Utz, P.J. Protein and peptide array analysis of autoimmune disease. Biotechniques (Suppl), Dec 66–69 (2002).Google Scholar
  9. 9.
    de Jager, W., te Velthuis, H., Prakken, B.J., Kuis, W., and Rijkers, G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10, 133–139 (2003).PubMedGoogle Scholar
  10. 10.
    Bock, C., et al., Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics 4, 609–618 (2004).CrossRefPubMedGoogle Scholar
  11. 11.
    Shao, W., et al., Optimization of rolling-circle amplified protein microarrays for multiplexed protein profiling. J Biomed Biotechnol 2003, 299–307 (2003).CrossRefPubMedGoogle Scholar
  12. 12.
    Anderson, K., Potter, A., Baban, D., and Davies, K.E. Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain 126, 2052–2064 (2003).CrossRefPubMedGoogle Scholar
  13. 13.
    Marienfeld, C., et al., Translational regulation of XIAP expression and cell survival during hypoxia in human cholangiocarcinoma. Gastroenterology 127, 1787–1797 (2004).CrossRefPubMedGoogle Scholar
  14. 14.
    Yamagiwa, Y., Marienfeld, C., Meng, F., Holcik, M., and Patel, T. Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: A novel mechanism of tumor cell survival. Cancer Res 64, 1293–1298 (2004).CrossRefPubMedGoogle Scholar
  15. 15.
    Hudelist, G., Pacher-Zavisin, M., Singer, C.F., Holper, T., Kubista, E., Schreiber, M., Manavi, M., Bilban, M., and Czerwenka, K. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res Treat 86, 281–291 (2004).CrossRefPubMedGoogle Scholar
  16. 16.
    Ghobrial, I.M., McCormick, D.J., Kaufmann, S.H., Leontovich, A.A., Loegering, D.A., Dai, N.T., Krajnik, K.L., Stenson, M.J., Melhem, M.F., Novak, A.J., Ansell, S.M., and Witzig T.E. Proteomic analysis of mantle cell lymphoma by protein microarray. Blood 105, 3722–3730 (2005).CrossRefPubMedGoogle Scholar
  17. 17.
    Gosmanov, A.R., Umpierrez, G.E., Karabell, A.H., Cuervo, R., and Thomason, D.B. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am J Physiol Endocrinol Metab 287, E8–E15 (2004).CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Grigoriy S. Chaga
    • 1
  1. 1.Clontech LaboratoriesMountain View

Personalised recommendations